Prevention of Programmed Hyperleptinemia and Hypertension by Postnatal Dietary Omega-3 Fatty Acids.
From: School of Anatomy and Human Biology, The University of Western Australia, Nedlands, Perth, Western Australia 6009, Australia.
Endocrinology
- Publish Date: Jan 2006
- ISSN: 0013-7227
- Volume: 147
- Issue: 1
- Pages: 599-606
- Medium: Print
- Language: English
- Citation (JAMA): Wyrwoll Caitlin S, Mark Peter J, Mori Trevor A, et al. Prevention of Programmed Hyperleptinemia and Hypertension by Postnatal Dietary Omega-3 Fatty Acids.. Endocrinology Jan 2006;147:599-606
Abstract
Fetal programming is now recognized as a key determinant of the adult phenotype, with major implications for adult-onset diseases including hypertension. Two mediators of fetal programming are maternal nutrition and fetal glucocorticoid exposure. Recent studies show that postnatal dietary manipulations can exacerbate programming effects, but whether programming effects can be attenuated by postnatal dietary manipulations, and thus provide a possible therapeutic strategy, is unknown. In this study, we tested the hypothesis that a postnatal diet enriched with long-chain omega-3 fatty acids attenuates programmed hyperleptinemia and hypertension. Pregnant rats were treated with dexamethasone (Dex) from d 13 to term, and offspring were cross-fostered to mothers on either a standard diet or a diet high in omega-3 fatty acids and remained on these diets postweaning. Maternal Dex reduced birthweight and delayed the onset of puberty in offspring. Hyperleptinemia (associated with elevated leptin mRNA expression in adipose tissue) and hypertension were evident in offspring by 6 months of age in Dex-exposed animals consuming a standard diet, but these effects were completely blocked by a high omega-3 diet. These results demonstrate for the first time that manipulation of postnatal diet can limit adverse outcomes of fetal programming, with programmed hyperleptinemia and hypertension prevented by a postnatal diet enriched with omega-3 fatty acids. This raises the possibility that dietary supplementation with omega-3 fatty acids may provide a viable therapeutic option for preventing and/or reducing adverse programming outcomes in humans.
Mesh Headings (Keywords): Animals, Animals, Newborn, Body Weight, Dietary Fats, Energy Intake, Fatty Acids, Omega-3, Female, Hyperlipidemias, Hypertension, Leptin, Male, Pregnancy, Pregnancy, Animal, Rats, Rats, Wistar
Check for Full Text / PubMed Unique Identifier (PMID): 16210371
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.